By proceeding, you agree to our Terms of Use and Privacy Policy.
For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with Gamma Biosciences, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space.
27-29 June 2023
The 3rd Next Generation Gene Therapy Vectors Summit is a gathering of industry leaders focused on advancing the field of gene therapy. With the emergence of new platforms and the need for safer vectors, the industry has rapidly expanded over the last
Event Ended
USA
Paid
Boston